Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1998 Sep;95(1):18–25. doi: 10.1046/j.1365-2567.1998.00565.x

T-cell receptor Vbeta gene expression in experimental lupus nephritis.

M Sutmuller 1, H J Baelde 1, S Ouellette 1, E De Heer 1, J A Bruijn 1
PMCID: PMC1364371  PMID: 9767452

Abstract

A limited T-cell receptor (TCR) Vbeta repertoire employed by autoreactive T cells may be related to the development and course of autoimmune diseases. Vbeta repertoire skewing has been observed not only in man, but also in animal models of several human autoimmune diseases, such as MRL-lpr mice, which spontaneously develop a systemic lupus erythematosus (SLE)-like disease. Murine chronic graft-versus-host disease (GVHD) is an inducible model for SLE, involving direct interaction between donor T cells and recipient B cells. It is not known whether Vbeta-specific T-cell subsets are pathogenically involved in this model. Retroviral superantigens such as Mls-1 are known to have a profound impact on the TCR Vbeta repertoire in mice. Restriction of the peripheral TCR repertoire may result from intrathymic expression of Mls-1, which causes deletion of T cells expressing Vbeta6, -7, -8.1, or -9. Mls-1 incompatibility between donor and recipient can be used to determine the involvement of these TCR Vbeta families in GVHD. In the present study we induced GVHD in several strain combinations to investigate TCR Vbeta gene expression during GVHD, and the effect of Mls-1 incompatibility on the TCR Vbeta repertoire. TCR Vbeta gene expression was determined using an RNase protection assay. Our results indicate that T cells expressing the Vbeta2 or Vbeta16 chain play an important pathogenetic role, while T cells bearing the Vbeta1 or Vbeta6 chain may be related to self-limitation of the lupus-like disease in this model.

Full text

PDF
18

Images in this article

21Figure 1
on p.21
23Figure 4
on p.23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe J., Kotzin B. L., Jujo K., Melish M. E., Glode M. P., Kohsaka T., Leung D. Y. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4066–4070. doi: 10.1073/pnas.89.9.4066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Acha-Orbea H., Mitchell D. J., Timmermann L., Wraith D. C., Tausch G. S., Waldor M. K., Zamvil S. S., McDevitt H. O., Steinman L. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 1988 Jul 15;54(2):263–273. doi: 10.1016/0092-8674(88)90558-2. [DOI] [PubMed] [Google Scholar]
  3. Acha-Orbea H., Palmer E. Mls--a retrovirus exploits the immune system. Immunol Today. 1991 Oct;12(10):356–361. doi: 10.1016/0167-5699(91)90066-3. [DOI] [PubMed] [Google Scholar]
  4. Auffray C., Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem. 1980 Jun;107(2):303–314. doi: 10.1111/j.1432-1033.1980.tb06030.x. [DOI] [PubMed] [Google Scholar]
  5. Boylston A. W., Clarke G. R., Lancaster F. C., Reyburn H. Evidence for an endogenous superantigen deleting human V beta 2 positive T-lymphocytes. Ann N Y Acad Sci. 1995 Jul 7;756:113–116. doi: 10.1111/j.1749-6632.1995.tb44494.x. [DOI] [PubMed] [Google Scholar]
  6. Bruijn J. A., Van Elven E. H., Corver W. E., Oudshoorn-Snoek M., Fleuren G. J. Genetics of experimental lupus nephritis: non-H-2 factors determine susceptibility for renal involvement in murine chronic graft-versus-host disease. Clin Exp Immunol. 1989 May;76(2):284–289. [PMC free article] [PubMed] [Google Scholar]
  7. Bruijn J. A., van Elven E. H., Hogendoorn P. C., Corver W. E., Hoedemaeker P. J., Fleuren G. J. Murine chronic graft-versus-host disease as a model for lupus nephritis. Am J Pathol. 1988 Mar;130(3):639–641. [PMC free article] [PubMed] [Google Scholar]
  8. Chang J. C., Smith L. R., Froning K. J., Schwabe B. J., Laxer J. A., Caralli L. L., Kurland H. H., Karasek M. A., Wilkinson D. I., Carlo D. J. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9282–9286. doi: 10.1073/pnas.91.20.9282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chiocchia G., Boissier M. C., Fournier C. Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies. Eur J Immunol. 1991 Dec;21(12):2899–2905. doi: 10.1002/eji.1830211202. [DOI] [PubMed] [Google Scholar]
  10. Choi Y., Kappler J. W., Marrack P. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus. Nature. 1991 Mar 21;350(6315):203–207. doi: 10.1038/350203a0. [DOI] [PubMed] [Google Scholar]
  11. Clarke G. R., Humphrey C. A., Lancaster F. C., Boylston A. W. The human T cell antigen receptor repertoire: skewed use of V beta gene families by CD8+ T cells. Clin Exp Immunol. 1994 May;96(2):364–369. doi: 10.1111/j.1365-2249.1994.tb06568.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cohen P. L., Eisenberg R. A. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol Today. 1992 Nov;13(11):427–428. doi: 10.1016/0167-5699(92)90066-G. [DOI] [PubMed] [Google Scholar]
  13. Drake C. G., Kotzin B. L. Superantigens: biology, immunology, and potential role in disease. J Clin Immunol. 1992 May;12(3):149–162. doi: 10.1007/BF00918083. [DOI] [PubMed] [Google Scholar]
  14. Festenstein H., Kumura S., Biasi G. Mls and tolerance. Immunol Rev. 1989 Feb;107:29–59. doi: 10.1111/j.1600-065x.1989.tb00002.x. [DOI] [PubMed] [Google Scholar]
  15. Forman J. D., Klein J. T., Silver R. F., Liu M. C., Greenlee B. M., Moller D. R. Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis. J Clin Invest. 1994 Oct;94(4):1533–1542. doi: 10.1172/JCI117494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Frankel W. N., Rudy C., Coffin J. M., Huber B. T. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature. 1991 Feb 7;349(6309):526–528. doi: 10.1038/349526a0. [DOI] [PubMed] [Google Scholar]
  17. Gold D. P. TCR V gene usage in autoimmunity. Curr Opin Immunol. 1994 Dec;6(6):907–912. doi: 10.1016/0952-7915(94)90012-4. [DOI] [PubMed] [Google Scholar]
  18. González-Quintial R., Theofilopoulos A. N. V beta gene repertoires in aging mice. J Immunol. 1992 Jul 1;149(1):230–236. [PubMed] [Google Scholar]
  19. Hawes G. E., Struyk L., van den Elsen P. J. Differential usage of T cell receptor V gene segments in CD4+ and CD8+ subsets of T lymphocytes in monozygotic twins. J Immunol. 1993 Mar 1;150(5):2033–2045. [PubMed] [Google Scholar]
  20. Hirose S., Tokushige K., Kinoshita K., Nozawa S., Saito J., Nishimura H., Shirai T. Contribution of the gene linked to the T cell receptor beta chain gene complex of NZW mice to the autoimmunity of (NZB x NZW)F1 mice. Eur J Immunol. 1991 Mar;21(3):823–826. doi: 10.1002/eji.1830210343. [DOI] [PubMed] [Google Scholar]
  21. Hodes R. J., Novick M. B., Palmer L. D., Knepper J. E. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus. J Immunol. 1993 Feb 15;150(4):1422–1428. [PubMed] [Google Scholar]
  22. Hosaka N., Nagata N., Miyashima S., Ikehara S. Attenuation of lpr-graft-versus-host disease (GVHD) in MRL/lpr spleen cell-injected SCID mice by in vivo treatment with anti-V beta 8.1,2 monoclonal antibody. Clin Exp Immunol. 1994 Jun;96(3):500–507. doi: 10.1111/j.1365-2249.1994.tb06057.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Howell M. D., Diveley J. P., Lundeen K. A., Esty A., Winters S. T., Carlo D. J., Brostoff S. W. Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10921–10925. doi: 10.1073/pnas.88.23.10921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Huang L., Soldevila G., Leeker M., Flavell R., Crispe I. N. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity. 1994 Dec;1(9):741–749. doi: 10.1016/s1074-7613(94)80016-2. [DOI] [PubMed] [Google Scholar]
  25. Jacobsson H., Lilliehök B., Blomgren H. Disappearance of specifically mlc-responsive lymphocytes in cba mice injected with cells from the h-2-compatible, m-antigen-incompatible strain c3h. Scand J Immunol. 1975;4(2):181–192. doi: 10.1111/j.1365-3083.1975.tb02615.x. [DOI] [PubMed] [Google Scholar]
  26. Janeway C. A., Jr Selective elements for the V beta region of the T cell receptor: Mls and the bacterial toxic mitogens. Adv Immunol. 1991;50:1–53. doi: 10.1016/s0065-2776(08)60821-4. [DOI] [PubMed] [Google Scholar]
  27. Kappler J. W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell. 1987 Apr 24;49(2):273–280. doi: 10.1016/0092-8674(87)90568-x. [DOI] [PubMed] [Google Scholar]
  28. Kappler J. W., Staerz U., White J., Marrack P. C. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature. 1988 Mar 3;332(6159):35–40. doi: 10.1038/332035a0. [DOI] [PubMed] [Google Scholar]
  29. Lewis R. M., Armstrong M. Y., André-Schwartz J., Muftuoglu A., Beldotti L., Schwartz R. S. Chronic allogeneic disease. I. Development of glomerulonephritis. J Exp Med. 1968 Oct 1;128(4):653–679. doi: 10.1084/jem.128.4.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lindberg C., Oldfors A., Tarkowski A. Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies. Eur J Immunol. 1994 Nov;24(11):2659–2663. doi: 10.1002/eji.1830241114. [DOI] [PubMed] [Google Scholar]
  31. MacDonald H. R., Acha-Orbea H. Diabetes. Superantigen as suspect. Nature. 1994 Sep 22;371(6495):283–284. doi: 10.1038/371283a0. [DOI] [PubMed] [Google Scholar]
  32. MacDonald H. R., Schneider R., Lees R. K., Howe R. C., Acha-Orbea H., Festenstein H., Zinkernagel R. M., Hengartner H. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature. 1988 Mar 3;332(6159):40–45. doi: 10.1038/332040a0. [DOI] [PubMed] [Google Scholar]
  33. Matossian-Rogers A., Festenstein H. Modification of murine T-cell cytotoxicity by preimmunization with M locus and H-2 incompatibilities. J Exp Med. 1976 Feb 1;143(2):456–461. doi: 10.1084/jem.143.2.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. McDermott M., Kastner D. L., Holloman J. D., Schmidt-Wolf G., Lundberg A. S., Sinha A. A., Hsu C., Cashin P., Molloy M. G., Mulcahy B. The role of T-cell receptor beta chain genes in the susceptibility to rheumatoid arthritis. Ann N Y Acad Sci. 1995 Jul 7;756:173–175. doi: 10.1111/j.1749-6632.1995.tb44502.x. [DOI] [PubMed] [Google Scholar]
  35. Niehues T., Gulwani-Akolkar B., Akolkar P. N., Tax W., Silver J. Unique phenotype and distinct TCR V beta repertoire in human peripheral blood alpha beta TCR+, CD4-, and CD8- double negative T cells. J Immunol. 1994 Feb 1;152(3):1072–1081. [PubMed] [Google Scholar]
  36. Okada C. Y., Weissman I. L. Relative V beta transcript levels in thymus and peripheral lymphoid tissues from various mouse strains. Inverse correlation of I-E and Mls expression with relative abundance of several V beta transcripts in peripheral lymphoid tissues. J Exp Med. 1989 May 1;169(5):1703–1719. doi: 10.1084/jem.169.5.1703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Paliard X., West S. G., Lafferty J. A., Clements J. R., Kappler J. W., Marrack P., Kotzin B. L. Evidence for the effects of a superantigen in rheumatoid arthritis. Science. 1991 Jul 19;253(5017):325–329. doi: 10.1126/science.1857971. [DOI] [PubMed] [Google Scholar]
  38. Parish N. M., Acha-Orbea H., Simpson E., Qin S. X., Lund T., Cooke A. A comparative study of T-cell receptor V beta usage in non-obese diabetic (NOD) and I-E transgenic NOD mice. Immunology. 1993 Apr;78(4):606–610. [PMC free article] [PubMed] [Google Scholar]
  39. Rocha B., von Boehmer H. Peripheral selection of the T cell repertoire. Science. 1991 Mar 8;251(4998):1225–1228. doi: 10.1126/science.1900951. [DOI] [PubMed] [Google Scholar]
  40. Sarukhan A., Gombert J. M., Olivi M., Bach J. F., Carnaud C., Garchon H. J. Anchored polymerase chain reaction based analysis of the V beta repertoire in the non-obese diabetic (NOD) mouse. Eur J Immunol. 1994 Aug;24(8):1750–1756. doi: 10.1002/eji.1830240805. [DOI] [PubMed] [Google Scholar]
  41. Singer P. A., Balderas R. S., McEvilly R. J., Bobardt M., Theofilopoulos A. N. Tolerance-related V beta clonal deletions in normal CD4-8-, TCR-alpha/beta + and abnormal lpr and gld cell populations. J Exp Med. 1989 Dec 1;170(6):1869–1877. doi: 10.1084/jem.170.6.1869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Singer P. A., McEvilly R. J., Noonan D. J., Dixon F. J., Theofilopoulos A. N. Clonal diversity and T-cell receptor beta-chain variable gene expression in enlarged lymph nodes of MRL-lpr/lpr lupus mice. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7018–7022. doi: 10.1073/pnas.83.18.7018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Singer P. A., Theofilopoulos A. N. T-cell receptor V beta repertoire expression in murine models of SLE. Immunol Rev. 1990 Dec;118:103–127. doi: 10.1111/j.1600-065x.1990.tb00814.x. [DOI] [PubMed] [Google Scholar]
  44. Sinha A. A., Lopez M. T., McDevitt H. O. Autoimmune diseases: the failure of self tolerance. Science. 1990 Jun 15;248(4961):1380–1388. doi: 10.1126/science.1972595. [DOI] [PubMed] [Google Scholar]
  45. Sutmuller M., Ekstijn G. L., Ouellette S., De Heer E., Bruijn J. A. Non-MHC genes determine the development of lupus nephritis in H-2 identical mouse strains. Clin Exp Immunol. 1996 Nov;106(2):265–272. doi: 10.1046/j.1365-2249.1996.d01-852.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Urban J. L., Kumar V., Kono D. H., Gomez C., Horvath S. J., Clayton J., Ando D. G., Sercarz E. E., Hood L. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell. 1988 Aug 12;54(4):577–592. doi: 10.1016/0092-8674(88)90079-7. [DOI] [PubMed] [Google Scholar]
  47. Vandenbark A. A., Hashim G. A., Offner H. T cell receptor peptides in treatment of autoimmune disease: rationale and potential. J Neurosci Res. 1996 Feb 15;43(4):391–402. doi: 10.1002/(SICI)1097-4547(19960215)43:4<391::AID-JNR1>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  48. Via C. S., Shearer G. M. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol Today. 1988 Jul-Aug;9(7-8):207–213. doi: 10.1016/0167-5699(88)91215-7. [DOI] [PubMed] [Google Scholar]
  49. Whitham R. H., Kotzin B. L., Buenafe A. C., Weinberg A. D., Jones R. E., Hashim G. A., Hoy C. M., Vandenbark A. A., Offner H. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides. J Neurosci Res. 1993 Jun 1;35(2):115–128. doi: 10.1002/jnr.490350202. [DOI] [PubMed] [Google Scholar]
  50. Whitham R. H., Wingett D., Wineman J., Mass M., Wegmann K., Vandenbark A., Offner H. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen. J Neurosci Res. 1996 Jul 15;45(2):104–116. doi: 10.1002/(SICI)1097-4547(19960715)45:2<104::AID-JNR3>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  51. Wucherpfennig K. W., Ota K., Endo N., Seidman J. G., Rosenzweig A., Weiner H. L., Hafler D. A. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science. 1990 May 25;248(4958):1016–1019. doi: 10.1126/science.1693015. [DOI] [PubMed] [Google Scholar]
  52. Yanagi Y., Hirose S., Nagasawa R., Shirai T., Mak T. W., Tada T. Does the deletion within T cell receptor beta-chain gene of NZW mice contribute to autoimmunity in (NZB X NZW)F1 mice? Eur J Immunol. 1986 Sep;16(9):1179–1182. doi: 10.1002/eji.1830160925. [DOI] [PubMed] [Google Scholar]
  53. Zamvil S. S., Mitchell D. J., Lee N. E., Moore A. C., Waldor M. K., Sakai K., Rothbard J. B., McDevitt H. O., Steinman L., Acha-Orbea H. Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. J Exp Med. 1988 May 1;167(5):1586–1596. doi: 10.1084/jem.167.5.1586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. de Alborán I. M., Gonzalo J. A., Kroemer G., Leonardo E., Marcos M. A., Martínez C. Attenuation of autoimmune disease and lymphocyte accumulation in MRL/lpr mice by treatment with anti-V beta 8 antibodies. Eur J Immunol. 1992 Aug;22(8):2153–2158. doi: 10.1002/eji.1830220829. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES